# US 2014/0271583 A1 · Cryopreservation of viable human skin substitutes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0271583 A1
- Document ID: US20140271583A1
- Status: Published application
- Kind: A1
- Application number: 14/208,439
- Filed: 2014-03-13
- Published: 2014-09-18
- Earliest claimed: 2013-03-13
- Assignees: Stratatech Corporation
- Applicants: Stratatech Corporation
- Inventors: B. Lynn Allen-Hoffmann; John C. Pirnstill; Kenneth R. Gratz; Allen R. Comer
- Web page: https://patentgrep.com/patent/US20140271583A1

## CPC

- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates generally to systems and methods for preparing, storing, shipping and using skin equivalents made by organotypic culture. In particular, the present invention relates to systems and methods for cryopreserving viable skin substitutes.

## Claims

### Claim 1

A method of cryopreserving an organotypically cultured skin equivalent to maintain viable tissue comprising:
treating an organotypically cultured skin equivalent in a cryoprotectant solution in a single step;
packaging said organotypically cultured skin equivalent to provide a packaged skin equivalent; and
freezing said packaged organotypically cultured skin equivalent to provide a cryopreserved skin equivalent.

### Claim 2 (depends on 1)

The method of claim 1, wherein said cryoprotectant is provided in a solution comprising about 21% to 70% of said solution by volume.

### Claim 3 (depends on 1)

The method of claim 1, wherein said cryoprotectant is glycerol.

### Claim 4 (depends on 1)

The method of claim 1, wherein said freezing further comprises freezing said organotypically cultured skin equivalent in the absence of substantial excess cryoprotectant.

### Claim 5 (depends on 1)

The method of claim 1, wherein said freezing further comprises freezing at about −80 C.

### Claim 6 (depends on 1)

The method of claim 1, wherein said freezing further comprises direct exposure to temperatures ranging from about −50 C to −100 C.

### Claim 7 (depends on 1)

The method of claim 1, wherein said packaging further comprises enclosing said cryopreserved skin equivalent in a sterile bag and enclosing said sterile bag in a second bag.

### Claim 8 (depends on 1)

The method of claim 1, wherein said organotypically cultured skin equivalents comprise NIKS cells.

### Claim 9 (depends on 8)

The method of claim 8, wherein said NIKS cells comprise an exogenous nucleic acid sequence encoding an exogenous polypeptide.

### Claim 10 (depends on 1)

The method of claim 1, wherein said skin equivalent retains viability after thawing.

### Claim 11 (depends on 10)

The method of claim 10, wherein said cryopreserved skin equivalent has an A550 of at least 50% of a reference skin equivalent as determined by an MTT assay.

### Claim 12 (depends on 1)

The method of claim 1, further comprising thawing said cryopreserved skin equivalent and applying said thawed skin equivalent to a patient in need thereof, wherein said thawed skin equivalent is not rinsed prior to said application to said patient.

### Claim 13

A method of thawing a cryopreserved skin equivalent prior to application to a patient, comprising:
warming said cryopreserved skin equivalent; and
contacting said cryopreserved skin equivalent with a diffusion mediator comprising a tissue compatible solution to allow removal of said cryoprotectant solution by diffusion.

### Claim 14 (depends on 13)

The method of claim 13, wherein said warming comprises exposure to room temperature at the site of use.

### Claim 15 (depends on 13)

The method of claim 13, wherein said diffusion mediator is selected from the group consisting of an absorbent medium, a membrane, and a dialysis bag.

### Claim 16 (depends on 15)

The method of claim 15, wherein said absorbent medium is selected from the group consisting of Telfa pads, foam pads, gauze pads, and cellulosic pads containing said tissue compatible medium.

### Claim 17 (depends on 13)

The method of claim 13, wherein said tissue compatible solution is a buffered solution.

### Claim 18 (depends on 1)

A method of treating a patient comprising
providing a packaged cryopreserved skin equivalent produced according to claim 1;
warming said cryopreserved skin equivalent;
aseptically transferring said cryopreserved skin equivalent from said package;
contacting said cryopreserved skin equivalent with an absorbent medium comprising a tissue compatible solution to allow removal of said cryoprotectant solution by diffusion; and
applying said cryopreserved skin equivalent to said patient.

### Claim 19

A cryopreserved skin equivalent equilibrated with a cryoprotectant, said skin equivalent being substantially free of excess cryoprotectant on the exterior surface of said skin equivalent.

### Claim 20 (depends on 19)

A system comprising the skin equivalent of claim 19 placed on an absorbent medium.

### Claim 21 (depends on 19)

A method for treating a wound comprising:
providing the packaged cryopreserved skin equivalent of claim 19; and
applying said skin equivalent to a wound under conditions such that said skin equivalent contacts said wound.

### Claim 22

A kit comprising a cryopreserved skin substitute, a diffusion mediator, and a tissue compatible solution.

### Claim 23 (depends on 22)

The kit of claim 22, wherein said cryopreserved skin substitute is packaged in a sealable enclosure.

### Claim 24 (depends on 22)

The kit of claim 22, wherein said cryopreserved skin substitute is provided in a culture vessel packaged in said bag.

### Claim 25

A method comprising:
providing a culture dish comprising a cell culture substrate movable between defined upper and lower positions in said culture dish,
forming a skin equivalent on said cell culture substrate, wherein said cell culture substrate is at said upper position,
lowering said cell culture substrate to said lower position for further processing.

### Claim 26 (depends on 25)

The method of claim 25, wherein said further processing comprises treating said skin equivalent with a cryoprotectant solution.

### Claim 27 (depends on 26)

The method of claim 26, wherein said further processing comprises freezing said treated skin equivalent in said culture dish.

### Claim 28

A method of producing a cryopreserved skin equivalent comprising:
providing a culture dish comprising an insert movable between upper and lower positions in said culture dish, said insert having a bottom planar surface formed from a porous membrane,
forming a dermal equivalent comprising fibroblast cells on said porous membrane in said insert, wherein said insert is placed in said upper position said in culture dish,
culturing said fibroblast cells to form a dermal equivalent,
applying keratinocytes to said dermal equivalent,
culturing said keratinocytes in a culture medium under conditions such that said keratinocytes form a skin equivalent comprising stratified epithelium,
removing said culture medium,
lowering said insert to said lower position,
treating said skin equivalent with a cryoprotectant solution, and
freezing said skin equivalent in said culture dish.

### Claim 29 (depends on 1)

A method of treating a patient comprising:
providing a packaged cryopreserved skin equivalent produced according to claim 1;
thawing said cryopreserved skin equivalent; and
applying said thawed skin equivalent to said patient in need thereof, wherein said thawed skin equivalent is not rinsed prior to said application to said patient.
